QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.027946v1 71/1/323    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fugere, M. Articles by Day, R. Search for Related Content PubMed PubMed Citation Articles by Fugere, M. Articles by Day, R.

Short Polybasic Peptide Sequences Are Potent Inhibitors of PC5/6 and PC7: Use of Positional Scanning-Synthetic Peptide Combinatorial Libraries as a Tool for the Optimization of Inhibitory Sequences

Département de Pharmacologie, Institut de Pharmacologie de Sherbrooke, Facultéde Médecine, Université de Sherbrooke, Sherbrooke, Québec, Canada (M.F., R.D.); Torrey Pines Institute for Molecular Studies, San Diego, California (J.A., R.A.H.); and Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, New Orleans, Louisiana (I.L.)

Positional scanning-synthetic peptide combinatorial libraries (PS-SPCLs) are powerful molecular tools to identify enzyme substrate and potent inhibitory sequences and also to provide crucial information about active site determinants. PS-SPCLs have been surveyed for furin, proprotein convertase (PC)2, PC1/3, and PACE4 and proven efficient to identify potent peptidyl inhibitors in the low nanomolar range for furin and PC1/3. We report herein the screenings of nonamidated and acetylated hexapeptide PS-SPCLs for PC5/6A and PC7. The L-configuration library surveys distinctively revealed that L-Arg, L-Lys, and sometimes L-His in all six positions would generate the most potent inhibitors for both enzymes. Based on this clear polybasic preference, L-poly-Arg peptides ranging from four to nine residues were assayed. Inhibitory potency of these polybasic peptides increased with chain length, making nona-L-Arg a potent nanomolar inhibitor of PC5/6A and PC7 (K_i of 150 and 120 nM). PC5/6 and PC7 inhibition by nona-L-arginine was equivalent to that of furin (K_i of 114 nM) (J Biol Chem 275: 36741-36749, 2000). Nona-D-arginine was a more potent inhibitor of PC5/6 and PC7 than its levorotatory version (K_i of 19 and 81 nM), reminiscent of furin (K_i of 1.3 nM) (J Biol Chem 279:36788-36794, 2004). Our data indicate that certain poly-arginine peptides represent potent inhibitors targeting PCs of the constitutive secretory pathway (furin, PC5/6, and PC7). We conclude that basic residues within PC peptide inhibitors might be responsible for targeting PCs in general and for inhibitory potency, but that select amino acid changes will be necessary to acquire true specificity toward a single PC.

Address correspondence to: Dr. Robert Day, Département de Pharmacologie, FacultédeMédecine, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12^e Ave. Nord., Sherbrooke, Québec, Canada J1H 5N4. E-mail: robertday{at}usherbrooke.ca

This article has been cited by other articles:

				S. A. Shiryaev, A. G. Remacle, B. I. Ratnikov, N. A. Nelson, A. Y. Savinov, G. Wei, M. Bottini, M. F. Rega, A. Parent, R. Desjardins, et al. Targeting Host Cell Furin Proprotein Convertases as a Therapeutic Strategy against Bacterial Toxins and Viral Pathogens J. Biol. Chem., July 20, 2007; 282(29): 20847 - 20853. [Abstract] [Full Text] [PDF]